The authors concluded that one dose of metoclopramide significantly reduced postoperative nausea and vomiting for patients having surgery under general anaesthesia. Publication bias was possible, the included trials were of variable quality, and the generalisability of the findings was uncertain, making the reliability of the authors' conclusions unclear.
Study selection
Published randomised controlled trials (RCTs) comparing one perioperative 10mg intravenous dose of metoclopramide, with placebo or no treatment, for patients aged 18 years or older, were eligible for inclusion. Trials had to report the incidence of early (one-to six-hour) or 24-hour postoperative nausea and vomiting. They were excluded if they investigated emergency medicine, non-surgical patients, or multiple perioperative metoclopramide doses, or if metoclopramide was used as a treatment rather than for prevention. Trials, in which another antiemetic was used, were included if a direct comparison of metoclopramide and placebo could be made. Trials published by Yoshitaka Fujii were excluded, as their reliability had been questioned.
Most of the included trials investigated patients undergoing minor or major gynaecological surgery. Some were of patients undergoing laparoscopic cholecystectomy, abdominal surgery, cataract extraction, or other surgical procedures. The anaesthetics were thiopental, isoflurane, nitrous oxide, fentanyl, propofol, sevoflurane, etomidate, halothane, desflurane, sufentanil, atracurium, enflurane or methohexital. The primary outcomes were 24-hour nausea and vomiting, combined and separate, and early nausea and vomiting, combined and separate. Secondary outcomes were the need for rescue antiemetic therapy and adverse events.
Two authors independently selected the trials for the review, with disagreements resolved by discussion. Where agreement could not be reached another investigator was consulted.
Assessment of study quality
The quality of the included trials was assessed using a modified Jadad scale. This covered randomisation, validity of randomisation, double-blinding, allocation concealment, and completeness of follow-up, with a maximum score of five.
Two authors independently assessed the quality of the included trials, and disagreements were resolved by discussion. Where agreement could not be reached another reviewer was consulted.
Data extraction
The number of events in each group was extracted and used to calculate odds ratios, with 95% confidence intervals. For adverse events, their presence or absence was extracted and converted to incidence.
Two reviewers independently extracted data into a predefined form. Discrepancies were resolved through discussion, or another reviewer was consulted.
